Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bob smith who wrote (18986)	4/13/1998 6:38:00 PM
From: Hippieslayer	Read Replies (1) \| Respond to of 32384

LGND is like a fine cigar. It will take time for it to age before it is ready to be smoked. I think this thread does the stock an injustice because of the hype involved. LGND, so far, has navigated the rough biotech sea fairly well. I think once they can get the FDA to approve PAnretin (even though it's not a block buster drug but may have applications other than what it will be approved for --see that link I posted several posts back) LGND will enter into a new growth stage. But as I've said time and time agian, lgnd looks to be dead money for awhile. And to let you know, I'm as frustrated as you are with it's performance.